Moreover, the 36-month beta value for IVVD is 0.67. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IVVD is 67.73M and currently, short sellers hold a 10.46% of that float. On July 25, 2024, IVVD’s average trading volume was 602.62K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IVVD) stock’s latest price update
Invivyd Inc (NASDAQ: IVVD)’s stock price has gone rise by 7.20 in comparison to its previous close of 1.25, however, the company has experienced a 6.35% increase in its stock price over the last five trading days. globenewswire.com reported 2024-07-01 that WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets today.
IVVD’s Market Performance
Invivyd Inc (IVVD) has experienced a 6.35% rise in stock performance for the past week, with a 5.51% rise in the past month, and a -40.97% drop in the past quarter. The volatility ratio for the week is 8.65%, and the volatility levels for the past 30 days are at 9.97% for IVVD. The simple moving average for the past 20 days is 13.18% for IVVD’s stock, with a -48.89% simple moving average for the past 200 days.
Analysts’ Opinion of IVVD
Many brokerage firms have already submitted their reports for IVVD stocks, with Guggenheim repeating the rating for IVVD by listing it as a “Buy.” The predicted price for IVVD in the upcoming period, according to Guggenheim is $9 based on the research report published on April 05, 2024 of the current year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see IVVD reach a price target of $10, previously predicting the price at $4. The rating they have provided for IVVD stocks is “Overweight” according to the report published on March 26th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to IVVD, setting the target price at $4 in the report published on December 19th of the previous year.
IVVD Trading at -15.65% from the 50-Day Moving Average
After a stumble in the market that brought IVVD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.21% of loss for the given period.
Volatility was left at 9.97%, however, over the last 30 days, the volatility rate increased by 8.65%, as shares surge +10.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.71% lower at present.
During the last 5 trading sessions, IVVD rose by +6.35%, which changed the moving average for the period of 200-days by -17.79% in comparison to the 20-day moving average, which settled at $1.1905. In addition, Invivyd Inc saw -65.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IVVD starting from MCGUIRE TERRANCE, who sale 112,381 shares at the price of $1.66 back on May 29 ’24. After this action, MCGUIRE TERRANCE now owns 4,688,079 shares of Invivyd Inc, valued at $186,575 using the latest closing price.
Adimab, LLC, the 10% Owner of Invivyd Inc, sale 5,000,000 shares at $3.95 during a trade that took place back on Jan 19 ’24, which means that Adimab, LLC is holding 21,687,906 shares at $19,750,000 based on the most recent closing price.
Stock Fundamentals for IVVD
Current profitability levels for the company are sitting at:
- -72.88 for the present operating margin
- 0.32 for the gross margin
The net margin for Invivyd Inc stands at -68.39. The total capital return value is set at -1.23. Equity return is now at value -81.87, with -73.08 for asset returns.
Based on Invivyd Inc (IVVD), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -103.58. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -58.77.
Currently, EBITDA for the company is -205.75 million with net debt to EBITDA at 0.86. When we switch over and look at the enterprise to sales, we see a ratio of -9.18. The receivables turnover for the company is 3.46for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.77.
Conclusion
To wrap up, the performance of Invivyd Inc (IVVD) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
